# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-14-007643
Filing Date
2014-10-31
Accepted
2014-10-31 15:45:40
Documents
9
Period of Report
2014-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | QUARTERLY REPORT | f10q0914_actiniumpharma.htm | 10-Q | 375399
2 | CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL AND ACCOUNT | f10q0914ex31i_actiniumpharma.htm | EX-31.1 | 13054
3 | CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL AND ACCOUNT | f10q0914ex32i_actiniumpharma.htm | EX-32.1 | 5712
| Complete submission text file | 0001213900-14-007643.txt |  | 4547684

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL INSTANCE FILE | atnm-20140930.xml | EX-101.INS | 531931
5 | XBRL SCHEMA FILE | atnm-20140930.xsd | EX-101.SCH | 60286
6 | XBRL CALCULATION FILE | atnm-20140930_cal.xml | EX-101.CAL | 24479
7 | XBRL DEFINITION FILE | atnm-20140930_def.xml | EX-101.DEF | 218004
8 | XBRL LABEL FILE | atnm-20140930_lab.xml | EX-101.LAB | 478055
9 | XBRL PRESENTATION FILE | atnm-20140930_pre.xml | EX-101.PRE | 311765

Mailing Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36374 | Film No.: 141186552
SIC: 2834 Pharmaceutical Preparations